no statement of use filed
on 25 Oct 2021
Last Applicant/ Owned by
615 Arapeen Drive
Salt Lake City
UT
84108
Serial Number
88595964 filed on 28th Aug 2019
Registration Number
N/A
Correspondent Address
John C. Stringham
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"CELL"
"CELL" Academic support, namely, providing clinical programs, academic conferences, training, mentoring and fellowships in the field of clinical trials, technology transfer, product development, optimization, manufacturing and commercialization; educational services in the field of cellular therapy and regenerative medicine Biological preparations for others, namely, human cells and tissue for sRead More
Business consulting and industry collaboration in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials, applications for drug approval and product development; providing product commercialization assistance in the field of cellular therapy and regenerative medicine; commercialization services in the field of cellular therapy and regenerative medicine
Academic support, namely, providing clinical programs, academic conferences, training, mentoring and fellowships in the field of clinical trials, technology transfer, product development, optimization, manufacturing and commercialization; educational services in the field of cellular therapy and regenerative medicine
Contract manufacturing, namely, manufacture of cellular therapies and regenerative medicines; conducting manufacturing support, namely, development of operating procedures and batch records, cell expansion, master and working cell bank production and clinical trials in the field of cellular therapy and regenerative medicine
Conducting clinical trials and research for others in the field of cellular therapy and regenerative medicine; providing medical and scientific research information in the field of clinical trials for cellular therapy and regenerative medicine; Product research and development; Product development consultation; Product research and development services for others in the field of cellular therapy and regenerative medicine; scientific development in the field of stem cells and regenerative medicine; scientific research, discovery, technology transfer, process development and clinical trials in the field of cellular therapy and regenerative medicine
Biological and chemical products for use by clinicians in regenerative medicine for medical purposes, namely, cellular healing therapies and regenerative medicine
Biological preparations for others, namely, human cells and tissue for scientific and research use; Cells and biological tissue, namely, human tissue, stem cells, bone marrow, amniotic fluid and blood, for scientific research and use in cellular therapies; biological preparations for others, namely, human cells and tissue, for use in the research of treatment of degenerative diseases, wound healing, and cell therapy
Medical services in the field of cell-based therapies, including the use of biological cells and tissue in the delivery of cell-based therapies and regenerative medicine; Cell therapy services for the treatment of degenerative diseases, wounds, hematologic diseases, hematologic disorders and immuno-therapy; providing consultancy and information relating to these cell therapies for medical purposes; administration of cell therapies for the treatment of disorders, diseases, and injuries; medical services, namely, isolation of regenerative cells relating to cell therapy services, stem cell collection, processing, phenotypic characterization, infusion and storage for medical and scientific purposes; providing medical therapies, namely, stem cell therapies and therapies for regeneration of human tissues and cells; providing educational medical information about cellular therapy and regenerative medicines
No 88595964
No Service Mark
No 6300.485
No
No
No
No
No
No
No
No
26.17.01 -
Straight line(s), band(s) or bar(s)
26.17.05 -
Horizontal line(s), band(s) or bar(s)
26.17.13 -
Letters or words underlined and/or overlined by one or more strokes or lines
The mark consists of The word "CELL" underlined and to the left of the word "RE" written vertically to the left of the word "GEN" written horizontally.
| Status Date | Action Taken |
|---|---|
| 25th Oct 2021 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 25th Oct 2021 | ABANDONMENT - NO USE STATEMENT FILED |
| 23rd Mar 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 26th Jan 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 26th Jan 2021 | PUBLISHED FOR OPPOSITION |
| 06th Jan 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 17th Dec 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 16th Dec 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 15th Dec 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 15th Dec 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
